Buy Cadila Healthcare, target Rs 480.0 : Dr CK Narayan
Buy Cadila Healthcare Ltd. at a price target of Rs 480.0 and a stop loss at Rs 460.0 from entry point
Cadila Healthcare Ltd., incorporated in the year 1995, is a largecap company (having a market cap of ₹ 47706.41 Cr.) operating in Pharmaceuticals and health care sector.
Cadila Healthcare Ltd. key Products/Revenue Segments include Tablets which contributed ₹ 3368.10 Cr to Sales Value (47.22 % of Total Sales), Capsules which contributed ₹ 1349.30 Cr to Sales Value (18.91 % of Total Sales), Others which contributed ₹ 915.10 Cr to Sales Value (12.83 % of Total Sales), Injections which contributed ₹ 500.60 Cr to Sales Value (7.01 % of Total Sales), Other Operating Revenue which contributed ₹ 456.50 Cr to Sales Value (6.40 % of Total Sales), Bulk Drugs which contributed ₹ 399.80 Cr to Sales Value (5.60 % of Total Sales), Export Incentives which contributed ₹ 122.00 Cr to Sales Value (1.71 % of Total Sales), Royalty Income which contributed ₹ 17.60 Cr to Sales Value (0.24 % of Total Sales), Licence which contributed ₹ 2.70 Cr to Sales Value (0.03 % of Total Sales)for the year ending 31-Mar-2016.
For the quarter ended 31-12-2016, the company has reported a Consolidated sales of ₹ 2249.60 Cr., down -3.71% from last quarter Sales of ₹ 2336.30 Cr. and down -.81% from last year same quarter Sales of ₹ 2267.90 Cr. Company has reported net profit after tax of ₹ 274.00 Cr. in latest quarter. The company’s CEO is Mr.Pankaj R Patel. It's Board of Directors include Mr.Pankaj R Patel, Mr.Upen H Shah, Ms.Dharmishta N Rawal, Mr.Nitin D Parekh, Mr.Upen H Shah, Dr.Sharvil P Patel, Mr.Apurva S Diwanji, Mr.Humayun Dhanrajgir, Mr.Mukesh M Patel, Mr.Nitin Raojibhai Desai. Company has its registered office at "Zydus Tower",, Satellite Cross Roads,, Sarkhej Gandhinagar Highway, Ahmedabad, 380015, Gujarat. Company has Mukesh M Shah & Co. as its auditors. As on 31-03-2017, the company has a total of 1,023,742,600 shares outstanding.
Download ET Markets APP